Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
EDITOR The evidence base for anticoagulant treatment of non-rheumatic atrial
fibrillation is strongly influenced by just six trials, five of which
have been conveniently pooled. All suggest that anticoagulation with
warfarin is beneficial. Further analyses of the data have attempted
to stratify differing degrees of risk and potential
benefits.3 Evidence based guidelines that could convey
this information to clinicians would be welcome, but to suggest that
this evidence can then determine the level of risk at which
anticoagulant treatment should be recommended is misleading.
The decision to start anticoagulant treatment for atrial fibrillation
is difficult for both doctors and patients. On the one hand, in
addition to assessing the risk of a particular patient having a stroke
doctors must also consider the extent to which the patient wishes to
avoid one, which will vary with the patient's own health beliefs. Then
they must balance this with the knowledge that the treatment may also
cause the event it is meant to prevent. To this has to be added the
practical difficulties of anticoagulant treatment for the patient. What
evidence there is for this suggests that the patient's own preference
can show as much variation as clinical stratification according to
relative risk, on which guidelines would presumably be
based.4 The role of guidelines in this situation should
not therefore extend beyond making available the best evidence on which
the doctor and patient together can decide if anticoagulant treatment
is appropriate.
Thomson et al suggest that variations in recommendations for
anticoagulant treatment of atrial fibrillation could be overcome by
having a single body responsible for producing evidence based
guidelines.1 Might giving this responsibility to one body
lead to a form of medical tyranny in which only one view of who should
be offered anticoagulant treatment is held to be valid? Evidence based
medicine does not preclude the role of the patient in choosing or
declining a particular treatment.2
Warders Medical Centre, Tonbridge TN9 1LA.
© BMJ 1998
What can you learn from this BMJ paper? Read Leanne Tite's Paper+